CA2141056A1 - Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam - Google Patents

Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam

Info

Publication number
CA2141056A1
CA2141056A1 CA002141056A CA2141056A CA2141056A1 CA 2141056 A1 CA2141056 A1 CA 2141056A1 CA 002141056 A CA002141056 A CA 002141056A CA 2141056 A CA2141056 A CA 2141056A CA 2141056 A1 CA2141056 A1 CA 2141056A1
Authority
CA
Canada
Prior art keywords
taurultam
taurolidine
treatment
dentoalveolar
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002141056A
Other languages
English (en)
Other versions
CA2141056C (fr
Inventor
Rolf Wilhelm Pfirrmann
Peter Geistlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Rolf Wilhelm Pfirrmann
Peter Geistlich
Ed. Geistlich Sohne Ag Fur Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolf Wilhelm Pfirrmann, Peter Geistlich, Ed. Geistlich Sohne Ag Fur Chemische Industrie filed Critical Rolf Wilhelm Pfirrmann
Publication of CA2141056A1 publication Critical patent/CA2141056A1/fr
Application granted granted Critical
Publication of CA2141056C publication Critical patent/CA2141056C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002141056A 1992-07-30 1993-07-29 Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam Expired - Lifetime CA2141056C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929216155A GB9216155D0 (en) 1992-07-30 1992-07-30 Treatment of dentoalveolar infections
GB9216155.3 1992-07-30
PCT/GB1993/001607 WO1994003174A1 (fr) 1992-07-30 1993-07-29 Traitement d'infections dento-alveolaires avec la taurolidine et/ou le taurultam

Publications (2)

Publication Number Publication Date
CA2141056A1 true CA2141056A1 (fr) 1994-02-17
CA2141056C CA2141056C (fr) 2005-02-15

Family

ID=10719520

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141056A Expired - Lifetime CA2141056C (fr) 1992-07-30 1993-07-29 Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam

Country Status (5)

Country Link
EP (1) EP0652753A1 (fr)
JP (1) JPH07509483A (fr)
CA (1) CA2141056C (fr)
GB (1) GB9216155D0 (fr)
WO (1) WO1994003174A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300308T1 (de) * 1994-12-12 2005-08-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und spasmen an einer wunde
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
JP2001505532A (ja) * 1996-06-24 2001-04-24 バイオ―セイフ エンタープライジズ，インコーポレイテッド 抗菌性組成物
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
EP1797884B1 (fr) * 1999-12-06 2013-09-11 Geistlich Pharma AG Taurolidine ou de taurultame pour i' utilisation dans le traitement des tumeurs de la prostate, des poumons, du côlon et dans le traitement de la glioblastome multiforme récurrente
CA2393252A1 (fr) 1999-12-06 2001-06-07 Paul Calabresi Utilisation de composes renfermant du methylol pour traiter des tumeurs
CN100519525C (zh) 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
CA2462564C (fr) 2001-10-01 2012-07-10 Rhode Island Hospital Procede d'inhibition de metastases
DE10261241A1 (de) * 2002-12-20 2004-07-15 3M Espe Ag Dentalmaterial mit bakteriostatischen und/oder bakteriziden Substanzen
EP1442753B1 (fr) * 2003-02-03 2007-02-21 Polaschegg, Hans-Dietrich, Dr.techn. Composition pour la prévention des infections par prothèses endovasculaires
US20080177217A1 (en) * 2004-05-14 2008-07-24 Hans-Dietrich Polaschegg Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
EP1787627A1 (fr) 2005-11-17 2007-05-23 3M Innovative Properties Company Materiau d`empreinte dentaire antimicrobien
CA2812845A1 (fr) 2010-09-27 2012-04-05 Geistlich Pharma Ag Preparation de soins dentaires antimicrobienne
JP6863973B2 (ja) * 2015-10-07 2021-04-21 コーメディクス・インコーポレーテッド タウロリジンの皮膚浸透製剤
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH600878A5 (fr) * 1975-04-28 1978-06-30 Gaba Ag
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
DE69104608T2 (de) * 1991-07-04 1995-02-16 Weissenfluh Hawe Neos Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.

Also Published As

Publication number Publication date
WO1994003174A1 (fr) 1994-02-17
GB9216155D0 (en) 1992-09-09
EP0652753A1 (fr) 1995-05-17
CA2141056C (fr) 2005-02-15
JPH07509483A (ja) 1995-10-19

Similar Documents

Publication Publication Date Title
CA2141056A1 (fr) Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam
CA2293823A1 (fr) Derives de homo-erythromycine a -9-deoxo-9a-aza-9aa substitution en position 4
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
ZA9711606B (en) Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
CA2159450A1 (fr) 1-amidinophenyl-pyrrolidones piperidinones azetinones, inhibiteurs de l'agregation plaquettaire
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
CA2099994A1 (fr) Derives de phenylamidines utiles pour l'inhibition de l'agregation plaquettaire
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
CA2124677A1 (fr) Agents immunopotentialisateurs et leurs sels physiologiquement compatibles
CA2136331A1 (fr) Nouveaux usages pharmaceutiques d'enzymes de krill
CA2163361A1 (fr) Derives de substitution de guanidines, agents therapeutiques
FR2702148B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
DE69631609D1 (en) Tricyclische erythromycinderivate
CA2351429A1 (fr) Azalides a 13 elements et leur utilisation en tant qu'antibiotiques
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
CA2140927A1 (fr) Inhibiteurs d'agregation plaquettaire
MX9708611A (es) Compuestos de dialquiltiacumicina.
FI960658A (fi) Uudet bis-naftalimidit syövän hoitamiseksi
AU4568400A (en) Sphingomyelinase inhibitor
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
CA2141951A1 (fr) Inhibition de l'infection a retrovirus
CA2247232A1 (fr) Composition microbienne
ES8801267A1 (es) Procedimiento para preparar derivados de isoquinolinona
CA2197207A1 (fr) Combinaison inhibitrice de la vih protease

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130730

MKEC Expiry (correction)

Effective date: 20131009